Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

Autor: Hui Liu, Ting Wang, Yazi Yang, Ru Feng, Jiangtao Li, Chunli Zhang, Jiefei Bai, Yanping Ding, Guanghua Liu, Fei Wu, Xinan Lu, Jian Li, Ting He
Rok vydání: 2022
Předmět:
Zdroj: Blood. 140:10307-10308
ISSN: 1528-0020
0006-4971
DOI: 10.1182/blood-2022-166011
Databáze: OpenAIRE